EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel; Chair:; EASL Governing Board representative:; Panel members:

doi:10.1016/j.jhep.2021.05.025

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update

J Hepatol. 2021 Sep;75(3):659-689. doi: 10.1016/j.jhep.2021.05.025. Epub 2021 Jun 21.

Authors

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel; Chair:; EASL Governing Board representative:; Panel members:

Collaborators

Annalisa Berzigotti, Emmanouil Tsochatzis, Jerome Boursier, Laurent Castera, Nora Cazzagon, Mireen Friedrich-Rust, Salvatore Petta, Maja Thiele

PMID: 34166721
DOI: 10.1016/j.jhep.2021.05.025

Abstract

Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for the evaluation of liver disease severity and prognosis, focusing on the topics for which relevant evidence has been published in the last 5 years.

Keywords: NASH; cirrhosis; decompensation; elastography; serum markers of fibrosis.

Publication types

Practice Guideline

MeSH terms

Elasticity Imaging Techniques / methods*
Elasticity Imaging Techniques / trends
Europe
Gastroenterology / organization & administration
Gastroenterology / trends
Humans
Liver / diagnostic imaging
Liver Diseases / classification
Liver Diseases / diagnostic imaging*
Liver Diseases / physiopathology
Prognosis
Severity of Illness Index*